BMO Capital Markets assumed coverage on shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in a research note published on Monday, October 16th. The brokerage issued an outperform rating and a $52.00 price target on the stock.
Several other analysts have also recently issued reports on ACHC. Craig Hallum reiterated a buy rating and issued a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Zacks Investment Research cut shares of Acadia Healthcare from a buy rating to a hold rating in a research report on Tuesday, August 1st. UBS AG restated a positive rating and set a $60.00 price objective (up previously from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. BidaskClub cut shares of Acadia Healthcare from a hold rating to a sell rating in a research report on Friday, August 18th. Finally, Deutsche Bank AG raised their price objective on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a buy rating in a research report on Monday, July 31st. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of $49.31.
Shares of Acadia Healthcare (NASDAQ:ACHC) opened at 32.42 on Monday. Acadia Healthcare has a 1-year low of $30.91 and a 1-year high of $54.34. The company has a market cap of $2.85 billion, a P/E ratio of 356.26 and a beta of 1.07. The stock’s 50 day moving average price is $45.15 and its 200 day moving average price is $46.25.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, October 24th. The company reported $0.58 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The business had revenue of $716.70 million during the quarter, compared to the consensus estimate of $728.86 million. During the same period last year, the business posted $0.58 earnings per share. The firm’s quarterly revenue was down 2.4% on a year-over-year basis. Equities research analysts forecast that Acadia Healthcare will post $2.33 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/10/27/bmo-capital-markets-initiates-coverage-on-acadia-healthcare-company-inc-achc.html.
In related news, insider Scott Schwieger sold 2,891 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $52.85, for a total transaction of $152,789.35. Following the completion of the sale, the insider now directly owns 8,841 shares in the company, valued at $467,246.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Christopher L. Howard sold 53,713 shares of the company’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $2,722,711.97. Following the completion of the transaction, the executive vice president now owns 147,286 shares of the company’s stock, valued at $7,465,927.34. The disclosure for this sale can be found here. Insiders sold 3,085,693 shares of company stock valued at $157,729,099 over the last ninety days. Corporate insiders own 11.10% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of ACHC. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after acquiring an additional 270 shares during the last quarter. C M Bidwell & Associates Ltd. bought a new position in shares of Acadia Healthcare during the second quarter worth $205,000. Riverhead Capital Management LLC bought a new position in shares of Acadia Healthcare during the second quarter worth $209,000. Paloma Partners Management Co bought a new position in shares of Acadia Healthcare during the first quarter worth $217,000. Finally, Rathbone Brothers plc bought a new position in shares of Acadia Healthcare during the third quarter worth $223,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.